Nom du produit:3-(4-Benzyl-7-chloro-3-oxo-3,4-dihydroquinoxalin-2-yl)propanoic acid
IUPAC Name:3-(4-benzyl-7-chloro-3-oxo-3,4-dihydroquinoxalin-2-yl)propanoic acid
- CAS:568543-95-3
- Formule moléculaire:C18H15ClN2O3
- Pureté:97%
- Numéro de catalogue:CM221883
- Poids moléculaire:342.78
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:568543-95-3
- Formule moléculaire:C18H15ClN2O3
- Point de fusion:-
- Code SMILES:O=C(O)CCC1=NC2=C(C=CC(Cl)=C2)N(CC3=CC=CC=C3)C1=O
- Densité:
- Numéro de catalogue:CM221883
- Poids moléculaire:342.78
- Point d'ébullition:
- N° Mdl:MFCD03965247
- Stockage:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.